New Bosnalijek Web Page

As part of its marketing of the new non-prescription product Lysobact Spray, for the treatment of sore throat and inflammation of oropharyngeal mucosa, Bosnalijek has created an accompanying web page,

The Lysobact web page offers a host of useful information on oral antiseptics and indications for their application. The web page provides answers to common questions such as how to differentiate between various inflammations of the mouth and throat or how to differentiate between viral and bacterial inflammations. It offers information on forms of self-help for sore throats and advice on when to visit a doctor.
The web page provides interesting information on lysozyme, which is a natural component that makes the Lysobact product unique.

Tarik Čatić, a director of Corporate marketing with Bosnalijek, described the aim of the web page as better connecting patients and healthcare professionals, "With the Lysobact web page, Bosnalijek provides its patients with access to simple and useful information on this product and associated healthcare topics.” As an international pharmaceutical company, Bosnalijek provides extensive information on its products and works continuously to improve its marketing processes aimed at the promotion of healthcare through prevention and treatment.

Lysobact is a clinically proven effective and safe medicinal product used in the treatment of more than 50 million patients worldwide. Patients, doctors and pharmacists associate Lysobact with tradition, confidence, quality and safety. Lysobact Spray, a new and improved formulation in a practical modern form adapted to the needs and active lifestyle of persons who take care of their health, is now available. Lysobact Spray is available in two preferred flavours: refreshing peppermint and pleasantly soothing anise.

This product does not contain alcohol and is intended for use by adults and children over six years of age. Lysobact and Lysobact Spray are available at all pharmacies and dispensed without prescription.

More information on when, how and why you should choose one of the Lysobact products is available at

December 17, 2014
Previous news
Danish journalists were convinced of the top quality of Bosnalijek Cooperation Agreement Signed between Bosnalijek and Abdi Ibrahim – Bosna ... Bosnalijek breaks its own business records Record semi-annual performance of Bosnalijek in 2022 Bosnalijek Opens New Facility for Manufacturing Liquid and Semisolid Pha ... Two Bosnalijek Teams Won Valuable Prizes at Dolorex B2B Night Relay Race ... Professional Lecture for Doctors and Patients Held On the Occasion of th ... Bosnalijek signs cooperation agreement with Mylan, a global healthcare c ... Bosnalijek Appoints US Major General David L. Grange (Ret.) as the Board ... The Third Congress of Pharmacists from Montenegro held in Bečići
juni 12. 2024 |
BSNLR - Bosnalijek d.d. Sarajevo: 12,47 3,89%